FDA Investigator Heidy C Perales
Heidy C Perales has inspections in 2 countries as of 18 Aug 2023. Heidy C Perales has collaborated with a combinined 1226 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
14
Last Inspection Date:
18 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Australia
Co-Investigator(s):
Alan L Truong,
Alan P Kurtzberg,
Arsen Karapetyan,
Atul J Agrawal,
Binh T Nguyen,
Brian P Putz,
Brien C Fox,
Carla J Lundi,
Carolina D Vasquez,
Carr Sharpe,
Caryn M Mcnab,
Chelsea N Sealey,
Christopher R Czajka,
Craig K Hopkins,
Darren S Brown,
Deborah A Greco,
Deborah W Hsu,
Donna Mwilliams Hill,
Esther B Gamallo Herrera,
Gene D Arcy,
Hoover,
Hung H Do, MS,
Jai P Singh,
James M Timper Jr,
Joel D Hustedt,
John A Gonzalez,
Juanita Banuelos,
Judy C Nepsa,
Karen P Langer,
Katherine E Jacobitz,
Kathy Chiu,
Kathy Kuo,
Kelley,
Kenneth H Williams,
Kham Phommachanh,
Kim Lthomas Cruse,
Kim Thomas Chase,
Langer,
Lanita F Kelley,
Linda Thai,
LT Richard A Lyght,
Marcus F Yambot,
Maurice M Sheehan,
Michael D Garcia,
Nicholas A Violand,
Nicholas L Hunt,
Phal K Chhun,
Rumany C Penn, PharmD,
Saied A Asbagh,
Sangeeta M Khurana, PhD,
Santiago Gallardo Johnson,
Sean P Desbrow,
Sonya L Karsik,
Sparky L Bartee,
State Agency,
Stephanie A Slater, MS,
Sumit Sen,
Sundy Ven,
Sunita Masson,
Sunita Vij,
Taichun Qin, PhD,
Tamala P Bogan,
Tamala P Magee,
Terri L Dodds,
Thao T Kwan,
Tracey T Duong,
Truong Xuan Nguyen (Andy),
Uttaniti Limchumroon (Tom),
Vashti E Bocker,
Virgilio F Pacio, CSO,
Walden H Lee,
Yasamin Ameri,
Zachary A Bogorad
Heidy C Perales's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2023 | FDA 483 | Cosway Company, Inc. - Form 483, 2023-02-24 |
April, 2021 | FDA 483 | Ampak Chemicals Incorporated - Form 483, 2021-04-09 |
August, 2022 | FDA 483 | GoodFibers - Form 483, 2022-08-19 |
September, 2021 | FDA 483 | Best Formulations Inc. - Form 483, 2021-09-30 |
May, 2022 | FDA 483 | MICRO CONNECTION ENTERPRISES, INC., THE - Form 483, 2022-05-13 |
September, 2021 | EIR | Best Formulations Inc. - EIR, 2021-09-30 |
November, 2021 | EIR | Polypeptide Laboratories Inc - EIR, 2021-11-19 |
April, 2023 | FDA 483 | Exquisite Corporation - Form 483, 2023-04-26 |
November, 2023 | FDA 483 | Natren Inc. - Form 483, 2023-11-02 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more